Literature DB >> 1421956

Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.

R R Brutkiewicz1, S J Klaus, R M Welsh.   

Abstract

A time course study was performed in order to determine if vaccinia virus (VV)-infected targets were more susceptible to murine natural killer (NK) cell-mediated lysis during a discrete period of time postinfection. Activated NK cells were used in short-term (e.g. 4 h) assays in order to avoid a further in vitro activation of the NK cells by interferon (IFN) and to test the innate susceptibility of target cells to lysis. The sensitivity of VV-infected L929 cells to lysis by NK cells increased as the infection progressed, reached a peak at approximately 24 h postinfection, and subsequently declined to levels lower than that of uninfected cells. This window of vulnerability was not due to an increase in the number of effector/target cell conjugates, which continually decreased as the VV infection progressed. Triggering of NK cells was measured by the influx of 45Ca2+. Target cells treated with IFN induced less 45Ca2+ uptake, whereas cycloheximide treatment of targets caused a greater influx of 45Ca2+ into the effector cells. When L929 cells were infected with VV for various time intervals and used in the triggering assays, an enhanced triggering of the effectors corresponding to the time of enhanced susceptibility of the target cells to lysis was detected. Quantitative decreases in H-2Kk and Dk class I antigens were observed following VV infection of target cells as measured by FACS analysis using alloantibodies. Qualitative changes in H-2 class I antigens were also observed, as detected by a loss in VV-infected target cell susceptibility to lysis by allospecific cytotoxic T lymphocytes (CTL) at a time when they were highly sensitive to killing by NK cells and VV-specific CTL. These results show that virus-infected targets may become innately more sensitive to lysis by NK cells at discrete time points after infection and that the susceptibility to lysis correlates with enhanced triggering of NK cells and reduced H-2 class I antigen expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421956

Source DB:  PubMed          Journal:  Nat Immun        ISSN: 1018-8916


  20 in total

1.  Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.

Authors:  Yongxue Yao; Ping Li; Pratibha Singh; Allison T Thiele; David S Wilkes; Gourapura J Renukaradhya; Randy R Brutkiewicz; Jeffrey B Travers; Gary D Luker; Soon-Cheol Hong; Janice S Blum; Cheong-Hee Chang
Journal:  Cell Immunol       Date:  2007-08-02       Impact factor: 4.868

Review 2.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.

Authors:  M R Castrucci; S Hou; P C Doherty; Y Kawaoka
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.

Authors:  Norman Yeh; Nicole L Glosson; Nan Wang; Lynette Guindon; Carl McKinley; Hiromasa Hamada; Qingsheng Li; Richard W Dutton; Protul Shrikant; Baohua Zhou; Randy R Brutkiewicz; Janice S Blum; Mark H Kaplan
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

5.  Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression.

Authors:  P M Spence; V Sriram; L Van Kaer; J A Hobbs; R R Brutkiewicz
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

Review 6.  Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.

Authors:  R R Brutkiewicz; R M Welsh
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Vaccinia virus inhibits T cell receptor-dependent responses by human gammadelta T cells.

Authors:  Haishan Li; Carl O Deetz; Juan Carlos Zapata; Cristiana Cairo; Andrew M Hebbeler; Nadia Propp; Maria S Salvato; Yiming Shao; C David Pauza
Journal:  J Infect Dis       Date:  2006-11-20       Impact factor: 5.226

8.  Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo.

Authors:  Marina Babić; Michal Pyzik; Biljana Zafirova; Maja Mitrović; Višnja Butorac; Lewis L Lanier; Astrid Krmpotić; Silvia M Vidal; Stipan Jonjić
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

9.  Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: interferon-beta-mediated target cell protection does not correlate with up-regulation of HLA class I surface molecules.

Authors:  K Hamprecht; M Steinmassl
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

10.  Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Marcus Vieira; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Blood       Date:  2008-04-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.